Analysis and synthesis of GMP and non-GMP bulk drugs and pharmaceutical formulations
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N91023D00006
- Awardee
-
Alchem Laboratories Corporation UEI LD2KY6H7KMQ5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Task orders
- 1 $600,000 obligated
Award facts
- Opportunity
-
- 75N91022R00015A Solicitation number
- Combined order value
-
- $744,016 Current, with exercised options
- $4,092,087 Potential, with all options
- Last date to order 72% complete
- IDV ceiling 5% used
- $12,069,385.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 11 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Cancer Institute awarded a single-award indefinite-delivery contract to Alchem Laboratories Corporation on April 11, 2023, with a contract ceiling of $12.069 million and an ultimate completion date of April 10, 2028. The IDIQ calls for analysis and synthesis of GMP and non-GMP bulk drugs and pharmaceutical formulations to support the Institute's cancer research.
Alchem Laboratories Corporation is a custom research organization providing specialized services including custom organic synthesis, current Good Manufacturing Practice manufacturing, and analytical services for pharmaceutical development. The company is registered as a corporate, for-profit manufacturer based in Florida.
Place of performance is in Florida. The contract spans a five-year period from April 11, 2023 through April 10, 2028. No set-aside applied to this award. The IDIQ carries no minimum guarantee distinct from the ceiling value.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| The non-GMP synthesis of compounds for drug discovery | National Cancer Institute (NIH) | $600,000 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N91023D00006?
75N91023D00006 was awarded to Alchem Laboratories Corporation by National Cancer Institute (National Institutes of Health) on April 11, 2023.
How much is contract 75N91023D00006 worth?
Orders under 75N91023D00006 have obligated $600,000. Their combined current value, with exercised options, is $744,016. Their combined potential value, with all options, is $4,092,087. 75N91023D00006's own ceiling is $12,069,385.
How many orders have been placed under contract 75N91023D00006?
1 order has been placed under 75N91023D00006, the latest on September 20, 2026.
Who can order from contract 75N91023D00006?
75N91023D00006 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N91023D00006 competed?
The extent of competition for 75N91023D00006 was full and open competition. The government received 11 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV